171 related articles for article (PubMed ID: 17284325)
1. Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice.
Hasegawa H; Inoue A; Muraoka M; Yamanouchi J; Miyazaki T; Yasukawa M
Arthritis Res Ther; 2007; 9(1):R15. PubMed ID: 17284325
[TBL] [Abstract][Full Text] [Related]
2. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
Parietti V; Monneaux F; Décossas M; Muller S
Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
[TBL] [Abstract][Full Text] [Related]
3. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.
Hasegawa H; Inoue A; Kohno M; Muraoka M; Miyazaki T; Terada M; Nakayama T; Yoshie O; Nose M; Yasukawa M
Arthritis Rheum; 2006 Apr; 54(4):1174-83. PubMed ID: 16575871
[TBL] [Abstract][Full Text] [Related]
4. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB.
Saito K; Mori S; Date F; Hong G
Autoimmunity; 2015; 48(6):379-88. PubMed ID: 25847253
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.
Kulkarni O; Eulberg D; Selve N; Zöllner S; Allam R; Pawar RD; Pfeiffer S; Segerer S; Klussmann S; Anders HJ
J Pharmacol Exp Ther; 2009 Feb; 328(2):371-7. PubMed ID: 18997060
[TBL] [Abstract][Full Text] [Related]
10. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu.
Divekar AA; Dubey S; Gangalum PR; Singh RR
J Immunol; 2011 Jan; 186(2):924-30. PubMed ID: 21149603
[TBL] [Abstract][Full Text] [Related]
11. NKG2D
Yang D; Tian Z; Zhang M; Yang W; Tang J; Wu Y; Ni B
Sci Rep; 2017 Apr; 7(1):1288. PubMed ID: 28455530
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate inhibits oxidative stress-induced DNA damage and apoptosis in MRL-Fas(lpr) mice with autoimmune sialadenitis via upregulation of heme oxygenase-1 and Bcl-2.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2014 Feb; 47(1):13-22. PubMed ID: 24392721
[TBL] [Abstract][Full Text] [Related]
13. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
14. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
[TBL] [Abstract][Full Text] [Related]
15. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population.
Ko HJ; Cho ML; Lee SY; Oh HJ; Heo YJ; Moon YM; Kang CM; Kwok SK; Ju JH; Park SH; Park KS; Kim HY
J Autoimmun; 2010 Mar; 34(2):111-20. PubMed ID: 19665867
[TBL] [Abstract][Full Text] [Related]
16. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
[TBL] [Abstract][Full Text] [Related]
17. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
Akpek EK; Jabs DA; Gérard HC; Prendergast RA; Hudson AP; Lee B; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):185-90. PubMed ID: 14691172
[TBL] [Abstract][Full Text] [Related]
18. Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance.
Nishihara M; Terada M; Kamogawa J; Ohashi Y; Mori S; Nakatsuru S; Nakamura Y; Nose M
Arthritis Rheum; 1999 Dec; 42(12):2616-23. PubMed ID: 10616009
[TBL] [Abstract][Full Text] [Related]
19. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
Shimizu S; Nakashima H; Masutani K; Inoue Y; Miyake K; Akahoshi M; Tanaka Y; Egashira K; Hirakata H; Otsuka T; Harada M
Rheumatology (Oxford); 2004 Sep; 43(9):1121-8. PubMed ID: 15213333
[TBL] [Abstract][Full Text] [Related]
20. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
Yang CH; Tian L; Ling GS; Trendell-Smith NJ; Ma L; Lo CK; Stott DI; Liew FY; Huang FP
Eur J Immunol; 2008 Jun; 38(6):1664-76. PubMed ID: 18465774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
